Kazia Therapeutics
KZIA
11 hedge funds and large institutions have $2.9M invested in Kazia Therapeutics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
10% more funds holding
Funds holding: 10 → 11 (+1)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
28% less capital invested
Capital invested by funds: $4.01M → $2.9M (-$1.11M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$7.15K |
| 2 |
Citigroup
New York
|
+$4.29K |
| 3 |
CFN
Cordasco Financial Network
Naples,
Florida
|
+$1.07K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$715 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Truist Financial
Charlotte,
North Carolina
|
-$264K |
| 2 |
Renaissance Technologies
New York
|
-$189K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$184K |
| 4 |
SG Americas Securities
New York
|
-$72.9K |
| 5 |
Morgan Stanley
New York
|
-$43.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $2.26M | -$43.2K | -121 | -2% |
|
2
Envestnet Asset Management
Chicago,
Illinois
| $202K | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $192K | -$184K | -514 | -51% |
|
|
4
SG Americas Securities
New York
| $184K | -$72.9K | -204 | -30% |
|
5
Simplex Trading
Chicago,
Illinois
| $37K | -$18.6K | -52 | -35% |
|
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $8K | +$7.15K | +20 | New |
|
|
7
Citigroup
New York
| $5K | +$4.29K | +12 | New |
|
8
Wells Fargo
San Francisco,
California
| $4K | – | – | – |
|
|
SPIA
9
Steward Partners Investment Advisory
New York
| $1K | – | – | – |
|
|
10
Bank of America
Charlotte,
North Carolina
| $1K | +$715 | +2 | New |
|
|
CFN
11
Cordasco Financial Network
Naples,
Florida
| $1K | +$1.07K | +3 | New |
|
|
12
Truist Financial
Charlotte,
North Carolina
| – | -$264K | -628 | Closed |
|
|
13
Renaissance Technologies
New York
| – | -$189K | -449 | Closed |
|
14
UBS Group
Zurich,
Switzerland
| – | -$26K | -61 | Closed |
|
KZIA Hedge Fund Activity: Q1 2022 in Review
11 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q1 2022, worth a combined $2.9M — down 28% from $4.01M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new KZIA positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 4 trimmed.
The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $7.15K. The largest seller was Truist Financial, exiting entirely with an estimated $264K sold.
- 11 institutional investors held Kazia Therapeutics (KZIA) as of Q1 2022, up from 10 in Q4 2021.
- Funds reported $2.9M of Kazia Therapeutics stock for Q1 2022, down 28% quarter-over-quarter.
- 4 funds opened new Kazia Therapeutics positions in Q1 2022 and 3 closed out, a net change of +1 holder.
- The largest Kazia Therapeutics buyer in Q1 2022 was Royal Bank of Canada, an estimated $7.15K added.
- The largest Kazia Therapeutics seller in Q1 2022 was Truist Financial, an estimated $264K sold.
Based on aggregated 13F filings for Q1 2022.